Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
Clinical trial NCT05599789 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05599789
- Sponsor
- Peking Union Medical College Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2025-05-21
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.